Cargando…
The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Bone fragility has emerged as a new complication of diabetes. Several mechanisms in diabetes may influence bone homeostasis by impairing the action between osteoblasts, osteoclasts, and osteocytes and/or changing the structural properties of the bone tissue. Some of these mechanisms can potentially...
Autores principales: | Napoli, Nicola, Strollo, Rocky, Paladini, Angela, Briganti, Silvia I., Pozzilli, Paolo, Epstein, Sol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4124651/ https://www.ncbi.nlm.nih.gov/pubmed/25140176 http://dx.doi.org/10.1155/2014/690783 |
Ejemplares similares
-
Corrigendum to “The Alliance of Mesenchymal Stem Cells, Bone, and Diabetes”
por: Napoli, Nicola, et al.
Publicado: (2017) -
Effect of Calcitriol on Bone Turnover and Osteocalcin in Recent-Onset Type 1 Diabetes
por: Napoli, Nicola, et al.
Publicado: (2013) -
Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
por: Strollo, Rocky, et al.
Publicado: (2017) -
One size does not fit all glycemic targets for type 2 diabetes
por: Pozzilli, Paolo, et al.
Publicado: (2014) -
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths
por: Strollo, Rocky, et al.
Publicado: (2021)